Health Products

Lidocaine 2% and Epinephrine 1:100,000 Injection USP

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
D00205BA. Lidocaine 2% and Epinephrine 1:100,000 Injection USP
Recalling Firm
Novocol Pharmaceutical of Canada Inc.
25 Wolseley Court
Cambridge
N1R 6X3
Ontario
CANADA
Marketing Authorization Holder
Novocol Pharmaceutical of Canada Inc.
25 Wolseley Court
Cambridge
N1R 6X3
Ontario
CANADA
LiquidDIN 00151866Epinephrine 0.01 mg/mL

Introduction

Recalled Products

A. Lidocaine 2% and Epinephrine 1:100,000 Injection USP

Reason

Stability testing at the 15-month time point for the stability lot was out-of-specification for potency of epinephrine (Spec. - lower limit 90%; Actual - 87.2%)

Depth of distribution

Product fabricated for 3 distributors under their private labels with a total of 8 warehousing facilities (British Columbia (2), Alberta (2), Manitoba (1), Ontario (2), Quebec(1)) .  Products are destined for dental clinics.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime